MelliCell Header.jpg
Where diabetes meets the cure

 

We’re a talented group of scientists and entrepreneurs, but we are also people just like you, with loved ones who suffer from diabetes. Like you, we've been discouraged at the lack of progress being made in treatments for the disease. We created MelliCell to solve that unmet need. Our focus is at the cellular level, to understand and treat the root cause of diabetes, rather than treat symptoms. With our knowledge and background, we are working to create a product that delivers better treatments and overall improved health.


Why MelliCell?

 

MelliCell develops drug therapies that shrink fat cells in order to treat diabetes and other metabolic diseases like obesity. Fat cells are key in regulating hormones that affect metabolism. Fat cells expand as individuals gain weight and shrink as they lose weight. When a fat cell is enlarged, it causes metabolic hormones to be dysregulated in the body. Reducing the size of fat cells in the body is key to regaining metabolic regulation. Our focus on reducing the size of fat cells is distinct from other available metabolic therapies (such as GLP-1 analogs, SGLT2 inhibitors, anorexiants, intestinal lipase inhibitors, insulin secretagogues) which target other organs to inhibit absorption in the body or suppress appetite. 

Curious to find out more?


Cutting-edge technology and innovation

 

In order to understand fat cells and diabetes, we've developed a groundbreaking stem-cell platform. Through this platform, we can replicate human cells with unprecedented accuracy. This enables us to accelerate drug development that promotes weight loss and ultimately a cure for diabetes. Our technology has already been recognized by leaders in the pharmaceutical and biotechnology sector, and we are setting the trend for industry standards.


About diabetes

 

You or someone you know is likely affected by diabetes and you are not alone. In the United States, 1 out of every 11 people. has diabetes. That number is rapidly growing and is projected to be 1 in 3 by 2050. For such a pervasive disease, diabetes is widely misunderstood. Here are some helpful insights about the state of this disease on a global scale.


Partners
oac-logo-1920x1080.jpg
DRI-7931957-logo.png
LOGO_DTU.png
biolamina-ab-logo-vector.png
 

Get In Touch

Thanks for submitting!